SCHEMBL1144607

SCHEMBL1144607

CCOC(=O)/C(=C\N1CCCCC1)C(=O)C(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.39
GLO1 Q04760 1/20 0.39
ALDH1A1 P00352 5/20 0.38
GAA P10253 3/20 0.38
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
CYP2D6 P10635 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 6/20 0.35
LMNA P02545 5/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
MAPK1 P28482 2/20 0.34
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144608 1.00 NPSR1 (0.39) NPSR1GLO1ALDH1A1GAAMEN1
Trichloroethylene SCHEMBL28533493 0.92 ALDH1A1 (0.34) NPSR1GLO1ALDH1A1GAAMEN1
Hydrochloric Acid SCHEMBL28148061 0.84 NPSR1 (0.46) NPSR1GLO1ALDH1A1GAAMEN1
SCHEMBL1213472 0.83 RECQL (0.37) ALDH1A1MEN1KMT2ALMNA
SCHEMBL1213476 0.83 RECQL (0.37) ALDH1A1MEN1KMT2ALMNA
SCHEMBL21986966 0.81 GLO1 (0.56) NPSR1GLO1ALDH1A1GAAMEN1
SCHEMBL27834732 0.80 NPSR1 (0.40) NPSR1GLO1ALDH1A1GAAMEN1
SCHEMBL21974583 0.79 NPSR1 (0.39) NPSR1GLO1ALDH1A1GAAMEN1
SCHEMBL16692406 0.77 NPSR1 (0.48) NPSR1GLO1ALDH1A1GAAMEN1
SCHEMBL364547 0.75 NPSR1 (0.47) NPSR1GLO1ALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592578-B2 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters BASF SE (DE) 2013-11-26 US disclosed
US-8586750-B2 Method for the production of halogen-substituted 2-(aminomethylidene)-3-oxobutyric acid esters BASF SE (DE) 2013-11-19 US disclosed
US-20130041147-A1 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters BASF SE (DE) 2013-02-14 US disclosed
US-8314233-B2 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters BASF SE (DE) 2012-11-20 US disclosed
US-20110046371-A1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS BASF SE (DE) 2011-02-24 US disclosed
US-20110040096-A1 Method for the Production of Halogen-Substituted 2-(aminomethylidene)-3-oxobutyric Acid Esters BASF SE (DE) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130041147-A1 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters FFAR3, CBR3, NMBR NPSR1 191/4885GLO1 2741/4885ALDH1A1 1418/4885
US-20110046371-A1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS FFAR3, CBR3, NMBR NPSR1 191/4885GLO1 2741/4885ALDH1A1 1418/4885
US-20110040096-A1 Method for the Production of Halogen-Substituted 2-(aminomethylidene)-3-oxobutyric Acid Esters AADAC, CBR3, AOC3 NPSR1 2619/4885GLO1 996/4885ALDH1A1 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.